Healthcare provider profile · identity verified

Samim Giotis, MD

Family Practice · FORT WORTH, TX · NPI 1093194912

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	726	218
Amlodipine Besylate	Amlodipine Besylate	331	108
Lisinopril	Lisinopril	329	103
Rosuvastatin Calcium	Rosuvastatin Calcium	306	92
Levothyroxine Sodium	Levothyroxine Sodium	289	91
Losartan Potassium	Losartan Potassium	278	83
Pantoprazole Sodium	Pantoprazole Sodium	225	67
Metoprolol Succinate	Metoprolol Succinate	218	67
Pravastatin Sodium	Pravastatin Sodium	201	60
Metformin Hcl	Metformin Hcl	198	64
Montelukast Sodium	Montelukast Sodium	154	41
Sertraline Hcl	Sertraline Hcl	152	43
Omeprazole	Omeprazole	147	42
Tamsulosin Hcl	Tamsulosin Hcl	147	44
Alprazolam	Alprazolam	146	42
Gabapentin	Gabapentin	142	48
Trazodone Hcl	Trazodone Hcl	141	45
Albuterol Sulfate Hfa	Albuterol Sulfate	140	55
Simvastatin	Simvastatin	108	33
Allopurinol	Allopurinol	103	33
Hydrochlorothiazide	Hydrochlorothiazide	101	37
Furosemide	Furosemide	89	31
Fluticasone Propionate	Fluticasone Propionate	88	42
Alendronate Sodium	Alendronate Sodium	81	21
Eliquis	Apixaban	80	21
Ozempic	Semaglutide	77	19
Clopidogrel	Clopidogrel Bisulfate	70	22
Atenolol	Atenolol	68	18
Escitalopram Oxalate	Escitalopram Oxalate	67	22
Zolpidem Tartrate	Zolpidem Tartrate	67	30
Glimepiride	Glimepiride	63	21
Carvedilol	Carvedilol	61	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	23
Doxycycline Hyclate	Doxycycline Hyclate	60	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	18
Meloxicam	Meloxicam	59	26
Tizanidine Hcl	Tizanidine Hcl	59	29
Nifedipine Er	Nifedipine	58	15
Duloxetine Hcl	Duloxetine Hcl	56	22
Glipizide Er	Glipizide	54	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	15
Bupropion Xl	Bupropion Hcl	50	24
Jardiance	Empagliflozin	50	14
Potassium Chloride	Potassium Chloride	48	15
Fluoxetine Hcl	Fluoxetine Hcl	47	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	12
Lorazepam	Lorazepam	46	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	16
Famotidine	Famotidine	44	11
Valsartan	Valsartan	42	12
Metoprolol Tartrate	Metoprolol Tartrate	41	15
Donepezil Hcl	Donepezil Hcl	40	13
Olmesartan Medoxomil	Olmesartan Medoxomil	40	11
Glipizide	Glipizide	39	12
Buspirone Hcl	Buspirone Hcl	36	11
Ondansetron Odt	Ondansetron	36	15
Tramadol Hcl	Tramadol Hcl	36	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	30
Synthroid	Levothyroxine Sodium	34	12
Finasteride	Finasteride	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	13
Mirtazapine	Mirtazapine	32	15
Oxybutynin Chloride Er	Oxybutynin Chloride	32	14
Acetaminophen-Codeine	Acetaminophen With Codeine	31	13
Ezetimibe	Ezetimibe	31	11
Pregabalin	Pregabalin	31	12
Januvia	Sitagliptin Phosphate	30	12
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Prednisone	Prednisone	30	22
Indapamide	Indapamide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	18
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Levemir Flexpen	Insulin Detemir	25	suppressed
Naproxen	Naproxen	25	suppressed
Azithromycin	Azithromycin	24	22
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Temazepam	Temazepam	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Felodipine Er	Felodipine	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Linzess	Linaclotide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Terconazole	Terconazole	12	suppressed
Estradiol	Estradiol	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error